BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Bio
Development of 89Zr-5A10, a novel radiotracer to..
David Ulmert, MD, PhD:
Memorial Sloan-Kettering Cancer Center
Jason Lewis, PhD